Jianya M. Zhou
No. 79, Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Clinicopathological Characteristics, Molecular Findings, and Survival of Lung Cancer in Adults Aged <30 Years in China: A Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: July 01, 2026
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
Journal: JAMA
Published: June 17, 2026
Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Journal: Future oncology (London, England)
Published: June 03, 2026
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH).
Journal: Cancer biology & medicine
Published: May 22, 2026
Research Advances in Obstructive Sleep Apnea and Lung Cancer Comorbidity
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: May 13, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Journal: Lancet (London, England)
Published: April 23, 2026
Ubiquitin-dependent degradation of MBD3 by TRIM59 promotes lung adenocarcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: April 15, 2026
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Clinical outcomes of concomitant anti-PD-1 therapy and denosumab treatment in non-small cell lung cancer patients with bone metastasis: a single-center retrospective study.
Journal: Discover oncology
Published: January 29, 2026
Advances in Diagnosis and Targeted Therapy of KRASG12C Mutant Non-small Cell Lung Cancer
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: October 29, 2025
Artificial Intelligence in Post-translational Modification Site Prediction: Progress and Future Perspectives.
Journal: Genomics, proteomics & bioinformatics
Published: September 06, 2025
Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study.
Journal: American journal of cancer research
Published: September 01, 2025
Last Updated: 09/26/2026